Citation: | LIU Bao, WU Kai, SUN Ruiqin, JIANG Yuwei, ZHANG Xiaoqing. Practical synthesis of tofisopam[J]. Journal of China Pharmaceutical University, 2014, 45(6): 671-673. DOI: 10.11665/j.issn.1000-5048.20140609 |
[1] |
Kucharik R,Harris H.Block sensitivity to leukotrienes;inflammatory bowel disorders;psoriasis;antiarthritic agents:US,20040138209[P].2003-12-03[2004-07-15] .
|
[2] |
Molnárnésamu E,Simig TH.Process for the preparation of 3-[2-(3,4-dimethoxybenzoyl)-4,5-dimethoxyphenyl]-pentan-2-one:WO,2004054952[P].2003-12-16[2004-07-01] .
|
[3] |
Harris HW,Kucharik RF.Treatment of irritable bowel syndrome and nonulcer dyspepsia with substituted 2,3-benzodiazepines:US,6638928[P].2002-12-03[2003-10-28] .
|
[4] |
Zhang KH,Zhang YF,Hu WQ.A process for preparing a tofisopan intermediate:CN,101823945[P].2009-03-06[2010-09-08] .
|
[5] |
Bernard P.Phosphodiesterase inhibitors:US,20070161628[P].2006-11-20[2007- 07-12] .
|